RXST: the cashflow

MyFinsight

For the quarter ending 2025-09-30, RXST had -$10,723K decrease in cash & cash equivalents over the period. -$1,768K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-9,816	-19,976
Depreciation and amortization	854	1,561
Provision for bad debts	0	32
Amortization of right-of-use lease assets	0	0
Amortization of discount on short-term investments	2,144	4,541
Stock-based compensation	8,108	15,687
Provision for excess and obsolete inventory	66	1,250
Accounts receivable	-3,907	-1,960
Inventories	3,955	4,302
Prepaid and other assets	-322	-1,742
Accounts payable	-86	-1,491
Accrued expenses and other liabilities	1,557	-5,130
Net cash used in operating activities	-1,187	-13,208
Purchases of property and equipment	581	2,112
Maturities of short-term investments	60,000	110,000
Purchases of short-term investments	68,423	72,381
Net cash provided by (used in) investing activities	-9,004	35,507
Proceeds from issuance of common stock from public offering	0	0
Proceeds from issuance of common stock	131	2,764
Payments of debt issuance costs	-	0
Payments for employee taxes related to stock compensation	-642	-1,418
Principal payments on finance lease liabilities	19	16
Payments of deferred offering costs	0	0
Net cash provided by financing activities	-530	1,330
Effect of foreign exchange rate on cash, cash equivalents and restricted cash	-2	20
Net increase in cash, cash equivalents and restricted cash	-10,723	23,649
Cash and cash equivalents at beginning of period	17,456	-
Cash and cash equivalents at end of period	30,382	-

Unit: Thousand (K) dollars